Publications by authors named "Peter Ruvolo"

Claim this Profile
A
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill -ITD acute myeloid leukemia.
Sean M Post, Huaxian Ma, Prerna Malaney, Xiaorui Zhang, Marisa J L Aitken, Vivian R Ruvolo, Peter P Ruvolo

Haematologica· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.
Anneke D van Dijk, Ti'ara L Griffen, Yihua H Qiu, Fieke W Hoff, Endurance Toro, Peter P Ruvolo

Leukemia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAM kinases as regulators of cell death.
Sean M Post, Michael Andreeff, Courtney DiNardo, Joseph D Khoury, Peter P Ruvolo

Biochim Biophys Acta Mol Cell Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Stephen L Abrams, Shaw M Akula, Akshaya K Meher, Linda S Steelman, Agnieszka Gizak, Peter Ruvolo

Cells· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.
Fieke W Hoff, Anneke D van Dijk, Yihua Qiu, Peter P Ruvolo, Robert B Gerbing

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LGALS1 acts as a pro-survival molecule in AML.
Peter P Ruvolo, Huaxian Ma, Vivian R Ruvolo, Xiaorui Zhang, Sean M Post

Biochim Biophys Acta Mol Cell Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization.
Zhaoqi Liu, Akihide Yoshimi, Jiguang Wang, Hana Cho, Stanley Chun-Wei Lee, Peter Ruvolo

Cancer Discov· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A heavy metal baseline score predicts outcome in acute myeloid leukemia.
Maro Ohanian, Philippe Telouk, Steven Kornblau, Francis Albarede, Peter Ruvolo

Am J Hematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53/miR-34a-associated signaling targets expression in human pancreatic cancer.
Shaw M Akula, Peter P Ruvolo, James A McCubrey

Aging (Albany NY)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia".
Danilo Perrotti, Anupriya Agarwal, Claire M Lucas, Goutham Narla, Paolo Neviani, Peter P Ruvolo

Sci Transl Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.
Peter P Ruvolo, Chenyue W Hu, Yihua Qiu, Vivian R Ruvolo, Robin L Go

EBioMedicine· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC protein expression is an important prognostic factor in acute myeloid leukemia.
Maro Ohanian, Uri Rozovski, Rashmi Kanagal-Shamanna, Lynne V Abruzzo, Sanam Loghavi, Peter Ruvolo

Leuk Lymphoma· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of protein phosphatases in the cancer microenvironment.
Peter P Ruvolo

Biochim Biophys Acta Mol Cell Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectins as regulators of cell survival in the leukemia niche.
Peter P Ruvolo

Adv Biol Regul· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of MSC-derived galectin 3 in the AML microenvironment.
Peter P Ruvolo, Vivian R Ruvolo, Jared K Burks, YiHua Qiu, Rui-Yu Wang

Biochim Biophys Acta Mol Cell Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in -Mutant Acute Myeloid Leukemia.
Xuejie Jiang, Po Yee Mak, Hong Mu, Wenjing Tao, Duncan H Mak, Peter Ruvolo

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival.
Steven M Kornblau, Peter P Ruvolo, Rui-Yu Wang, V Lokesh Battula, Elizabeth J Shpall, Vivian R Ruvolo

Haematologica· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.
Hila Shaim, Zeev Estrov, David Harris, Mayra Hernandez Sanabria, Zhiming Liu, Peter Ruvolo

Front Immunol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms.
Peter P Ruvolo, Huaxian Ma, Vivian R Ruvolo, Xiaorui Zhang, Hong Mu

Haematologica· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.
Linda S Steelman, Steve L Abrams, Peter Ruvolo, Vivian Ruvolo, Lucio Cocco

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor status and genotype affect the bone marrow microenvironment in acute myeloid leukemia.
Rodrigo Jacamo, R Eric Davis, Xiaoyang Ling, Sonali Sonnylal, Zhiqiang Wang, Peter Ruvolo, Vivian Ruvolo

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.
Leonardo Mirandola, Elisa Pedretti, Jose A Figueroa, Raffaella Chiaramonte, Michela Colombo, Peter Ruvolo

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.
Stephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, Giovanni Ligresti, Alberto M Martelli

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSK-3 as a novel prognostic indicator in leukemia.
Peter P Ruvolo

Adv Biol Regul· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.
Katrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama, Cristina Ivan, Cristian Rodriguez-Aguayo, Peter P Ruvolo, Vivian R Ruvolo

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis